Feedback / Questions
NGN-401 - Neurogene
https://www.businesswire.com/news/home/20250428733532/en/Neurogene-Announces-Upcoming-Oral-Presentation-on-Monitoring-and-Treatment-to-Reverse-Rare-Complication-of-High-Dose-Gene-Therapy-at-the-ASGCT-Annual-Meeting
Apr 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next